{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:59Z","timestamp":1786119239764,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/cad.0b013e328329707c","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T06:07:04Z","timestamp":1242886024000},"page":"301-304","source":"Crossref","is-referenced-by-count":8,"title":["Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer"],"prefix":"10.1097","volume":"20","author":[{"given":"Kavitha P.","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homayoon","family":"Sanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Zell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.nrl.0000219732.33321.cc","article-title":"Neoplastic meningitis","volume":"12","author":"Chamberlain","year":"2006","journal-title":"Neurologist"},{"key":"R2-11-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1081\/CNV-50458","article-title":"Leptomeningeal metastasis","volume":"23","author":"DeAngelis","year":"2005","journal-title":"Cancer Invest"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.COC.0000018175.95100.D1","article-title":"Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature","volume":"26","author":"Lisenko","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"R4-11-20210203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1155\/2002\/659125","article-title":"Leptomeningeal carcinomatosis secondary to gastroesophageal adenocarcinoma: a case report and review of the literature","volume":"16","author":"Abdo","year":"2002","journal-title":"Can J Gastroenterol"},{"key":"R5-11-20210203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3904\/kjim.2007.22.4.304","article-title":"A case of gastric adenocarcinoma presenting as meningeal carcinomatosis","volume":"22","author":"Lee","year":"2007","journal-title":"Korean J Intern Med"},{"key":"R6-11-20210203","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2005.01.061","article-title":"Image of the month. Gastric signet-ring-cell carcinoma with leptomeningeal carcinomatosis","volume":"128","author":"Fuchizaki","year":"2005","journal-title":"Gastroenterology"},{"key":"R7-11-20210203","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3171\/JNS\/2008\/109\/8\/0268","article-title":"Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases","volume":"109","author":"Ali","year":"2008","journal-title":"J Neurosurg"},{"key":"R8-11-20210203","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1158\/1078-0432.CCR-06-2309","article-title":"Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma","volume":"13","author":"Vredenburgh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R9-11-20210203","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme","volume":"25","author":"Vredenburgh","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-11-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.6004\/jnccn.2005.0039","article-title":"Leptomeningeal metastases: current concepts and management guidelines","volume":"3","author":"Chowdhary","year":"2005","journal-title":"J Natl Compr Canc Netw"},{"key":"R11-11-20210203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-007-0014-5","article-title":"Leptomeningeal neoplasms","volume":"9","author":"Drappatz","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"R12-11-20210203","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","article-title":"Neoplastic meningitis","volume":"5","author":"Gleissner","year":"2006","journal-title":"Lancet Neurol"},{"key":"R13-11-20210203","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.11449","article-title":"Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis","volume":"97","author":"Cole","year":"2003","journal-title":"Cancer"},{"key":"R14-11-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.1986.4.1.68","article-title":"Combination intraventricular chemotherapy for meningeal neoplasia","volume":"4","author":"Giannone","year":"1986","journal-title":"J Clin Oncol"},{"key":"R15-11-20210203","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"R16-11-20210203","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J Clin Oncol"},{"key":"R17-11-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group","volume":"11","author":"Grossman","year":"1993","journal-title":"J Clin Oncol"},{"key":"R18-11-20210203","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol"},{"key":"R19-11-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1015752331041","article-title":"An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis","volume":"57","author":"Jaeckle","year":"2002","journal-title":"J Neurooncol"},{"key":"R20-11-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00148388","article-title":"Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies","volume":"5","author":"Stewart","year":"1987","journal-title":"J Neurooncol"},{"key":"R21-11-20210203","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jjco\/hyg118","article-title":"Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone","volume":"33","author":"Kim","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"R22-11-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1215\/15228517-2007-059","article-title":"A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies","volume":"10","author":"Groves","year":"2008","journal-title":"Neuro Oncol"},{"key":"R23-11-20210203","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2146\/ajhp060165","article-title":"Intrathecal topotecan in adult patients with neoplastic meningitis","volume":"63","author":"Gammon","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R24-11-20210203","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.21828","article-title":"Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis","volume":"106","author":"Chamberlain","year":"2006","journal-title":"Cancer"},{"key":"R25-11-20210203","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1200\/JCO.2005.06.053","article-title":"Intrathecal mafosfamide: a preclinical pharmacology and phase I trial","volume":"23","author":"Blaney","year":"2005","journal-title":"J Clin Oncol"},{"key":"R26-11-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","article-title":"Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis","volume":"21","author":"Blaney","year":"2003","journal-title":"J Clin Oncol"},{"key":"R27-11-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1215\/15228517-2008-075","article-title":"Experience with irinotecan for the treatment of malignant glioma","volume":"11","author":"Vredenburgh","year":"2008","journal-title":"Neuro Oncol"},{"key":"R28-11-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/theoncologist.11-2-165","article-title":"Changing paradigms \u2013 an update on the multidisciplinary management of malignant glioma","volume":"11","author":"Stupp","year":"2006","journal-title":"Oncologist"},{"key":"R29-11-20210203","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/14737140.8.5.707","article-title":"Topoisomerase I inhibitors for the treatment of brain tumors","volume":"8","author":"Feun","year":"2008","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328329707c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:32Z","timestamp":1786038512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200904000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328329707c","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}